I did some work on an IVIG product several years ago, and remember thinking that this kind of sh*t is what gives the whole pharmaceutical industry a bad name: overpriced, ineffective, and resource-intensive. I stopped working with them.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.